Wang Hye-Young, Ahn Jaeil, Lee Jonghoon, Kang Sang Chul, Kim Hyunil
Optipharm, Inc., Cheongju, Republic of Korea.
Optipharm Animal Disease Diagnostic Center, Cheongju, Republic of Korea.
Front Vet Sci. 2024 Aug 20;11:1421427. doi: 10.3389/fvets.2024.1421427. eCollection 2024.
Research quality can be improved with reliable and reproducible experimental results when animal experiments are conducted using laboratory animals with guaranteed microbiological and genetic quality through health monitoring. Therefore, health monitoring requires the rapid and accurate diagnosis of infectious diseases in laboratory animals.
This study presents a performance evaluation of a commercially available multiplex real-time PCR (mRT-PCR) assay for the rapid detection of 12 infectious pathogens (Set 1: Sendai virus [SeV, formally murine respirovirus], spp., , and ; Set 2: spp., Murine norovirus [MNV], Murine hepatitis virus [MHV], and spp.; Set 3: , , , and ). To evaluate the efficacy of the mRT-PCR assay, 102 clinical samples encompassing fecal and cecal specimens were analyzed. The resulting data were then compared with the findings from sequence analysis for validation.
The assay's detection limit ranged from 1 to 100 copies per reaction. Specificity testing involving various viruses and bacteria indicated no cross-reactivity between strains. Additionally, the assay exhibited good reproducibility, with mean coefficients of variation for inter- and intra assay variation below 3%. The overall positive rate was 52.9% ( = 54), with the mRT-PCR assay findings matching sequence analysis results ( = 1). MHV ( = 29, 28.4%) was the most prevalent pathogen, followed by spp. ( = 28, 27.5%), ( = 18, 17.6%), spp. ( = 14, 13.7%), MNV ( = 12, 11.8%), ( = 9, 8.8%), ( = 4, 3.9%), and ( = 1, 0.9%).
This assay offers a rapid turnaround time of 100 min, including 30 min for DNA preparation and 70 min for target DNA/RNA amplification. It ensures accuracy, minimizing false positives or negatives, making it a convenient tool for the simultaneous detection of infectious diseases in many samples. Overall, the propose‑d assay holds promise for the effective detection of the most important pathogens in laboratory animal health monitoring.
当使用通过健康监测保证微生物和遗传质量的实验动物进行动物实验时,可靠且可重复的实验结果能够提高研究质量。因此,健康监测需要对实验动物中的传染病进行快速准确的诊断。
本研究对一种市售的多重实时聚合酶链反应(mRT-PCR)检测方法进行了性能评估,用于快速检测12种传染性病原体(第1组:仙台病毒[SeV,正式名称为鼠呼吸道病毒]、 spp.、 spp.和 spp.;第2组: spp.、小鼠诺如病毒[MNV]、小鼠肝炎病毒[MHV]和 spp.;第3组: spp.、 spp.、 spp.和 spp.)。为了评估mRT-PCR检测方法的有效性,分析了102份包含粪便和盲肠标本的临床样本。然后将所得数据与序列分析结果进行比较以进行验证。
该检测方法的检测限为每个反应1至100个拷贝。涉及各种病毒和细菌的特异性测试表明菌株之间无交叉反应。此外,该检测方法具有良好的重复性,批间和批内变异的平均变异系数均低于3%。总体阳性率为52.9%( = 54),mRT-PCR检测结果与序列分析结果相符( = 1)。MHV( = 29,28.4%)是最常见的病原体,其次是 spp.( = 28,27.5%)、 spp.( = 18,17.6%)、 spp.( = 14,13.7%)、MNV( = 12,11.8%)、 spp.( = 9,8.8%)、 spp.( = 4,3.9%)和 spp.( = 1,0.9%)。
该检测方法的周转时间短,仅需100分钟,包括30分钟的DNA制备时间和70分钟的靶DNA/RNA扩增时间。它确保了准确性,最大限度地减少假阳性或假阴性,使其成为同时检测多个样本中传染病的便捷工具。总体而言,所提出的检测方法有望有效地检测实验动物健康监测中最重要的病原体。